Talon Therapeutics, Inc. 4
4 · Talon Therapeutics, Inc. · Filed Jul 18, 2013
Insider Transaction Report
Form 4
CARLSON CRAIG W
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2013-07-17−400,000→ 0 totalExercise: $0.64Exp: 2023-01-25→ Common Stock (400,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−705,000→ 0 totalExercise: $0.49Exp: 2020-12-21→ Common Stock (705,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−87,500→ 0 totalExercise: $0.76Exp: 2020-03-01→ Common Stock (87,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−400,000→ 0 totalExercise: $0.91Exp: 2022-02-17→ Common Stock (400,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2013-07-17−62,500→ 0 totalExercise: $0.92Exp: 2020-06-07→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]This stock option was cancelled pursuant to the terms of a Stock Purchase Agreement by and among Talon Therapeutics, Inc., Spectrum Pharmaceuticals, Inc. and Eagle Acquisition Merger Sub, Inc. dated July 16, 2013.